SCHEMBL17402575

SCHEMBL17402575

Brc1ccc(N(c2ccccc2)c2cccc(-c3ccccc3)c2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.52
MAPK1 P28482 1/20 0.52
TDP1 Q9NUW8 2/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
KDM4E B2RXH2 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
MAPT P10636 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
NPC1 O15118 1/20 0.39
NFKB1 P19838 1/20 0.39
RAB9A P51151 1/20 0.39
NFKB2 Q00653 1/20 0.39
RELA Q04206 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
MGLL Q99685 1/20 0.38
MAOA P21397 1/20 0.38
CRHBP P24387 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19429292 0.98 ALDH1A1 (0.50) ALDH1A1MAPK1TDP1L3MBTL1KDM4E
SCHEMBL16601114 0.98 ALDH1A1 (0.56) ALDH1A1MAPK1TDP1L3MBTL1KDM4E
SCHEMBL17402610 0.98 ALDH1A1 (0.56) ALDH1A1MAPK1TDP1L3MBTL1KDM4E
SCHEMBL17402546 0.98 ALDH1A1 (0.56) ALDH1A1MAPK1TDP1L3MBTL1KDM4E
SCHEMBL29407177 0.98 ALDH1A1 (0.56) ALDH1A1MAPK1TDP1L3MBTL1KDM4E
SCHEMBL19429299 0.96 ALDH1A1 (0.58) ALDH1A1MAPK1TDP1L3MBTL1KDM4E
SCHEMBL19660644 0.92 ALDH1A1 (0.58) ALDH1A1MAPK1TDP1L3MBTL1KDM4E
SCHEMBL17877964 0.90 ALDH1A1 (0.60) ALDH1A1MAPK1TDP1L3MBTL1KDM4E
SCHEMBL17740710 0.90 ALDH1A1 (0.60) ALDH1A1MAPK1TDP1L3MBTL1KDM4E
SCHEMBL18859401 0.90 CYP2A6 (0.44) ALDH1A1MAPK1TDP1L3MBTL1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230048456-A1 ORGANIC LIGHT-EMITTING ELEMENT AND COMPOSITION FOR ORGANIC MATERIAL LAYER THEREOF LT MATERIALS CO., LTD. (KR) 2023-02-16 US disclosed
US-20230013956-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2023-01-19 US disclosed
WO-2022060020-A1 ORGANIC LUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME 솔루스첨단소재 주식회사 2022-03-24 WO disclosed
WO-2021125835-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME 엘티소재주식회사 2021-06-24 WO disclosed
US-20170141311-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME, AND ELECTRONIC DEVICE COMPRISING SAME DUK SAN NEOLUX CO., LTD (KR) 2017-05-18 US disclosed
US-20170141311-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME, AND ELECTRONIC DEVICE COMPRISING SAME DUK SAN NEOLUX CO., LTD (KR) 2017-05-18 US disclosed
WO-2016003202-A2 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME, AND ELECTRONIC DEVICE COMPRISING SAME 덕산네오룩스 주식회사 2016-01-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230013956-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME ORC3, SUN2, CRY1 ALDH1A1 275/4885MAPK1 3667/4885TDP1 3238/4885
US-20170141311-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME, AND ELECTRONIC DEVICE COMPRISING SAME OR51E2, OR10J3, ORAI2 ALDH1A1 1863/4885MAPK1 2806/4885TDP1 1686/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.